Oslo University Hospital
Oslo, 0372, Norway
NCT Number: NCT03966573
This study evaluates function, quality of life and development of hip- and knee osteoarthritis minimum 15 years after unilateral femoral lengthening on people with idiopathic or post-traumatic anisomelia.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Oslo, 0372, Norway
This study has a cross-sectional design, where patients that completed femoral lengthening more than 15 years ago and fulfills the inclusion criteria's are invited to participate. Patients will undergo radiographic imaging to evaluate hip- and knee arthritis, axis deviaton and leg length discrepancy. To evaluate quality of life, function and pain, the participants will complete the forms EQ-5D-5L, Knee osteoarthritis outcome score (KOOS) and International physical activity questionnaire (IPAQ). Bilateral active hip and knee range of motion will be measured with hand held goniometer, and the functional tests 30 seconds sit to stand, hop tests and stair test will be conducted.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Evaluating arthritis in knee and hip bilaterally. Evaluating axis deficiancy and leg length discrepancy.
Other names: Knee front, knee side, lower extremity axis front, lower extremity axis side, pelvis front
Test function and physical capasity
Other names: 30 seconds sit to stand, single leg hop test, stair test, goniometric ROM measurement hip and knee
Forms for evaluating quality of life, pain, function
Other names: EQ-5D-5L, KOOS - knee osteoarthritis outcome score, IPAQ - international physical activity questionnaire
Time frame: One day
Radiographic imaging. Kellgren & Lawrence classification and joint space width will be measured
Time frame: one day
30 seconds sit to stand test, measuring strength in lower extremities
Time frame: one day
Single leg hop tests
Time frame: one day
Stair test, 18 steps up and down three times
Time frame: one day
participants report the extent of problems they have with endpoints 1-5, where 1 is no problems and 5 is not able to in the five dimensions mobility, self-care, usual activities, pain/discomfort and anxiety/depression. The questionnaire also contains a vertical analogue scale with the labelled endpoints 0-100 where 0 is the worst imaginable health state and 100 the best imaginable health state, giving a valuation of the participants own health state that can be used as a quantitative measure of health outcome based on the patients' own judgement
Time frame: one day
The participant answer questions regarding pain, function, stiffness and quality of life regarding knee pain. Endpoints 0 - 4, where 0 indicate no problems and 4 indicate extreme problems
Time frame: one day
Participants answer the amount of time being in vigorous activity, moderate activity, walking and sitting during the last 7 days. Answers are given in number of days in each of the activity categories, and time in hours and minutes on a regular day the actual week
Time frame: one day
Hand held goniometric measurement of active range of motion in hip and knee bilaterally
Oslo University Hospital
Other
Femoral Lengthening Might Impair Physical Function and Lead to Structural Changes in Adjacent Joints; 10 Patients With 27 to 34 Years Follow-up.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01894100
Arthritis, Bone Diseases
Smithfield, North Carolina, United States
View Trial DetailsNCT05122533
Bone Diseases, Bone Diseases, Developmental
Pécs, Baranya, Hungary
View Trial DetailsNCT04713397
Bone Diseases, Bone Diseases, Developmental
Istanbul, Sisli, Turkey (Türkiye)
View Trial DetailsNCT01803243
Bone Diseases, Bone Diseases, Developmental
Basel, Switzerland
View Trial Details